F3 and COVID-19: Thus, MSCs which are going to be used for COVID-19 should express only low levels of TF/CD142, since the molecule by itself may initiate the clotting process, and also because MSCs from different sources have been reported to express varying degrees of TF/CD142 (Moll et al., 2019).